findmyKOL

Leon Herndon, MD

Enriched profile

Professor of Ophthalmology; Chief, Glaucoma Division · Duke University Eye Center

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Durham, NC · Southeast · United StatesSpecialtyOphthalmologyFocusGlaucoma
Active KOLfindmyKOL type: EliteLatest publication2019Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Leon Herndon is Professor of Ophthalmology; Chief, Glaucoma Division at Duke University Eye Center. ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 21 Oct 2026

Leon W. Herndon Jr., MD, is Professor of Ophthalmology at Duke University Eye Center / Duke University School of Medicine, Durham, NC. The public record shows 134 publications with 7,570 citations (h-index 39), centered on Glaucoma. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 18 companies.

  • Top research focus: Glaucoma
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 18 companies

Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma4 trialsComa4 trialsRupture1 trialCataract1 trial

Research focus

OpenAlex concept fingerprint
Glaucoma

Drugs & molecules

across trials, industry payments and publications
Durystageneric · BimatoprostClinical trials—Industry payments28Publications—Dextenzageneric · DexamethasoneClinical trials—Industry payments5Publications—TravoprostClinical trials—Industry payments4Publications—Iyuzehgeneric · LatanoprostClinical trials—Industry payments2Publications—Rocklatangeneric · Latanoprost / netarsudilClinical trials—Industry payments2Publications—Vyzultageneric · Latanoprostene bunodClinical trials—Industry payments2Publications—Cequageneric · CyclosporineClinical trials—Industry payments1Publications—Miebogeneric · PerfluorohexyloctaneClinical trials—Industry payments1Publications—Oxervategeneric · CenegerminClinical trials—Industry payments1Publications—Rhopressageneric · NetarsudilClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Alcon Vision LLCClinical trials—Industry payments48Abbvie Inc.Clinical trials—Industry payments38New World Medical,Inc.Clinical trials—Industry payments27Glaukos CorporationClinical trials—Industry payments23Sight Sciences, Inc.Clinical trials—Industry payments21Allergan, Inc.Clinical trials—Industry payments12Alcon Research LLCClinical trials—Industry payments5Duke UniversityClinical trials5Industry payments—Ocular Therapeutix, Inc.Clinical trials—Industry payments5Bausch & Lomb Americas Inc.Clinical trials—Industry payments3Aerie Pharmaceuticals, Inc.Clinical trials—Industry payments2Genentech USA, Inc.Clinical trials—Industry payments2Ivantis, IncClinical trials—Industry payments2Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments2Thea Pharma Inc.Clinical trials—Industry payments2Dompe US, Inc.Clinical trials—Industry payments1Oculus Surgical Inc.Clinical trials—Industry payments1Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
39h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
18companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 21 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 21 Oct 2026

18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    85%
    Carbonic Anhydrase Inhibitor27.7%
    Dorzolamide-Timolol79%Dorzolamide Hcl9%Simbrinza5%Acetazolamide5%Brinzolamide2%
    Part D<11 patients
    Prostaglandin Analog25.8%
    Latanoprost88%Tafluprost7%Lumigan3%Travoprost3%
    Part D<11 patients

    + 6 more classes in this area

  • Cardiovascular

    7.8%
    Beta blocker7.8%
    Timolol Maleate100%
    Part D≥62 patients
  • Musculoskeletal

    2.8%
    Cyclooxygenase Inhibitor2.8%
    Ketorolac Tromethamine100%
    Part D≥45 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)8.8% facility · 91.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 21 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/leon-herndon-91a98758

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • X / Twitter

    x.com/dukeeyecenter/status/1811117256828436803

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 21 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    University of North Carolina at Chapel Hill School of Medicine

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • Board Certified

    American Board of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • Residency in Ophthalmology

    University of North Carolina Hospitals, Chapel Hill, NC

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • Clinical Fellowship in Glaucoma

    Duke University Medical Center, Durham, NC

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Editorial & leadership roles

journal and society appointments
  • President

    American Glaucoma Society (AGS), 2023-2024

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukeeyecenter.duke.edu ↗
  • Vice President

    American Glaucoma Society, 2022-2023

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukeeyecenter.duke.edu ↗
  • Founder

    North Carolina Glaucoma Club

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • Chair

    Glaucoma Clinical Committee, American Society of Cataract and Refractive Surgeons (ASCRS)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.